Biovision Laboratories manufactures the biovision medical reagents distributed by Genprice. The Biovision Medical reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact BioVision. Other Biovision products are available in stock. Specificity: Biovision Category: Medical
Test Assays information
L-Lysine 6-Oxidase, M. mediterranea |
|
P1500-10 |
Biovision |
10 mU |
EUR 1207.2 |
OptiPrep? Density Gradient Medium |
|
M1248-100 |
Biovision |
each |
EUR 301.2 |
OptiPrep? Density Gradient Medium |
|
M1248-250 |
Biovision |
each |
EUR 405.6 |
TotalExoRNA? Overall exosome immunocapture and RNA extraction kit (Biological Fluids/Cell Media, 20 reactions) |
|
K1220-20 |
Biovision |
each |
EUR 1462.8 |
ExoFACS? Kit for Cell Culture Media Exosomes |
|
K1236-20 |
Biovision |
each |
EUR 973.2 |
MEDICA 16 |
|
B7691-10 |
ApexBio |
10 mg |
EUR 277.2 |
MEDICA 16 |
|
B7691-5 |
ApexBio |
5 mg |
EUR 216 |
MEDICA 16 |
|
B7691-50 |
ApexBio |
50 mg |
EUR 999.6 |
ExoQuant? Tumor-derived Exosome enrichment and Quantification Assay Kit (Biological Fluids/Cell Media, Colorimetric) |
|
K1204-100 |
Biovision |
each |
EUR 1161.6 |
ExoQuant? Tumor-derived Exosome enrichment and Quantification Assay Kit (Biological Fluids/Cell Media, Luminometric) |
|
K1209-100 |
Biovision |
each |
EUR 1161.6 |
StemBoost? Fate Maintenance Medium (FMM) Cocktail |
|
S232-1 |
Biovision |
each |
EUR 301.2 |
StemBoost? Fate Maintenance Medium (FMM) Cocktail |
|
S232-5 |
Biovision |
each |
EUR 952.8 |
StemBoost? Fate Maintenance Medium (FMM) Cocktail |
|
S232-set |
Biovision |
each |
EUR 992.4 |
ExoPure? Reagent (Overall Exosome Isolation, cell media) |
|
M1002-25 |
Biovision |
each |
EUR 992.4 |
ExoPure? Reagent (Overall Exosome Isolation, cell media) |
|
M1002-50 |
Biovision |
each |
EUR 1083.6 |
Medicagol |
|
TBZ2124 |
ChemNorm |
unit |
Ask for price |
Medicarpin |
|
TB00529 |
ChemNorm |
5mg |
EUR 1016.4 |
